Bures Thomas
- SEC CIK
- 0001787029
No open-market purchases or sales filed in the past year.
Current role at each company
- BRKR Bruker CorpChief Accounting Officeras of Aug 18, 2026
- PVLA Palvella Therapeutics, Inc.Chief Financial Officeras of Feb 28, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bures Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BRKR Bruker Corp
Chief Accounting Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 (view filing) | Mar 10 | 1 day | Bures ThomasChief Accounting Officer | PPurchase | +500 | $47.40 | +$23.7K | +16.8%3.47K after |